Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Director's Dealing

3 Dec 2012 07:00

RNS Number : 5135S
Silvermere Energy PLC
03 December 2012
 



03 December 2012

 

Silvermere Energy plc

("Silvermere" or "the Company")

 

 

Director's Dealing

 

Silvermere, the independent oil and gas company with assets in the Gulf of Mexico announces the issue of new ordinary shares as set out below.

 

Director's Dealing

 

In accordance with the terms of his engagement, 34,783 new shares have been allotted to Stewart Dalby, a non-executive director of the Company, at a subscription price of 8.625p per share, this being the mid-market closing price on the specified date of 30 November 2012. Following the issue, Mr Dalby holds a total of 114,575 shares in the Company, representing approximately 0.39 per cent of the total shares in issue detailed below.

 

Application will be made for the new ordinary shares to be issued pursuant to the above arrangements to be admitted to trading on AIM and dealings are expected to commence on 10 December 2012.

 

Total Shares in Issue

 

Following the above share issue, the total number of ordinary shares in issue will be 29,239,356. Shareholders may use this number when calculating their percentage holding in the Company.

 

 

-ENDS-

 

 

For further information please contact:

 

Silvermere Energy plc

Andy Morrison, Chief Executive

 

 

 

 

+44(0)7980 878561

 

Merchant Securities Limited (Nominated Adviser and Broker)

Lindsay Mair/Virginia Bull

 

Peterhouse Corporate Finance Limited

Jon Levinson

 

 

+ 44(0)20 7628 2200 

 

 

+44(0)20 7469 0937

 

Bishopgate Communications

Nick Rome

 

+44(0)20 7562 3350

 

 

About Silvermere Energy Plc

 

The Company has a 33.33 per cent working interest and 20.00 per cent net entitlement interest in the Mustang Licence Area, an area within the southern half of the north-west quarter and northern half of the south-west quarter of the Block 818-L field as defined in State of Texas Oil and Gas Lease numbers 108873 and 108874. The Mustang Island 818-L field (the "Field"), located in Kleberg County waters of the Gulf of Mexico, is home to a field re-habilitation project targeting bypassed or only partially produced gas-condensate.

 

According to a recent update to the independent Competent Persons Report published at admission in August 2011, the Mustang asset, operated by Dominion Production Company, has an NPV10 of Proven and Probable reserves (P1 + P2) estimated to be US$14 million attributable to the Company's interest. It has an additional NPV10 of US$57million net from the potential upgrade of Possible (3P) reserves. These reserves are based on a projected three well programme.

 

Initially, Silvermere is focussed on progressing production from the I-1 re-entry well where it has a 16.66 per cent working interest with a view to underpinning its long-term objective of creating a bankable and cash generative oil and gas company during the medium term and then drilling the three new wells to access the NPV identified in the CPR.

 

The Company maintains an active business development programme which aims to identify and acquire additional valuable assets either in or near production. These will be used to expand the business and provide additional value to shareholders over time. The Company's search is focused on the US for the time being, both on-shore and off-shore, but may be expanded further afield in the future.

 

Silvermere is quoted on the AIM Market of the London Stock Exchange plc (AIM: SLME) with its offices in London.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFLLLBLLFFFBD
Date   Source Headline
13th Apr 20219:05 amRNSSecond Price Monitoring Extn
13th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:40 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:06 pmRNSSecond Price Monitoring Extn
6th Apr 20212:00 pmRNSPrice Monitoring Extension
31st Mar 20217:01 amRNSDA convertible loan note maturity date extension
31st Mar 20217:00 amRNSFinal results for the year ended 31 December 2020
29th Mar 20213:40 pmRNSAIM Director Disclosure Update
29th Mar 20212:00 pmRNSPrice Monitoring Extension
25th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20212:06 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20214:41 pmRNSSecond Price Monitoring Extn
18th Mar 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20212:06 pmRNSSecond Price Monitoring Extn
18th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 202111:05 amRNSSecond Price Monitoring Extn
18th Mar 202111:00 amRNSPrice Monitoring Extension
17th Mar 20212:06 pmRNSSecond Price Monitoring Extn
17th Mar 20212:01 pmRNSPrice Monitoring Extension
2nd Mar 20217:00 amRNSPortfolio News
11th Feb 20212:05 pmRNSSecond Price Monitoring Extn
11th Feb 20212:00 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSFundamentalVR and Device Authority Update
4th Feb 20217:00 amRNSPortfolio Update
28th Jan 20217:00 amRNSWyld Networks Fundraise and Update
15th Jan 202111:05 amRNSSecond Price Monitoring Extn
15th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20212:06 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:05 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSPortfolio Update
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:35 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSFurther FundamentalVR contract win
1st Dec 20205:30 pmRNSTotal Voting Rights
1st Dec 20207:00 amRNSFundamentalVR contract win
24th Nov 20207:00 amRNSFundamentalVR secures three-year follow on order
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 20207:00 amRNSResult of Fundraise
12th Nov 20204:36 pmRNSRetail Offer
12th Nov 20204:35 pmRNSEquity Fundraise of up to £2.2 million
10th Nov 20207:00 amRNSPortfolio Update
4th Nov 20207:00 amRNSInvestment in Talking Medicines Limited
2nd Nov 20204:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20204:35 pmRNSPrice Monitoring Extension
30th Oct 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.